Clinical Trial Update: TopQ Cut-off Score Validation Study for 3D OCT-1 Maestro

View source ↗

Summary

A completed clinical trial evaluating an OCT-1 Maestro device's TopQ cut-off score validation for normal eyes; results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Normal Eyes

Snippet

Sponsor: Topcon Medical Systems, Inc. | Conditions: Subjects Presenting With Normal Eyes | Status: COMPLETED | Results posted: 2017-01-31